Head Office +91 8729085230

Guru Angad Nagar,
New Delhi 110092

09.00 to 18.00 Monday to Saturday

Market Outlook:

Global Fill Finish Manufacturing Market is expected to offer an $ opportunity of USD 12,613.80 Million over the analysis period.

The Global Fill Finish Manufacturing Market Size was estimated USD 8,301.7 million during the base year i.e. 2021 and anticipated to expand at a compound annual growth rate (CAGR) of 9.68% during analysis period. 2022 to 2031. 

Global Market Size, Forecast, and Trend Over the Analysis Period 2021 - 2031:

Base Year2021
Forecast Year2022-2031
CAGR9.68%
Base Year Market Size (2021)USD 8,301.7 Million
Forecast Year Market Size (2031)USD 20,915.5 Million

Fill and finish is a process used to complete the packaging of medicinal products for delivery while also filling vials with vaccination. Majority of vaccine manufacturers fill and complete their products through third party service due to various advantages. The process of fill and finish carried out at in a very aseptic environment mostly being employed for vaccines, biologics products. 

The growth of the global market is poise to be expanded by the proliferation of biologics, vaccines, small molecules, by biopharmaceutical and biotechnology companies. As the demand for these products is increasing due to rise in disease prevalence and change in other market dynamics.

The growth of global fill finish manufacturing market is attributed to the significant role being played by contract manufacturing organizations (CMO), CDMOs becoming more and more prevalent in various biotech firms. 

Furthermore, a large number of smaller biopharmaceutical and biotechnological firms outsource their fill-finish operations to CDMOs firms. As the advantage are bring offered by them enhance their scale of production. 

Global Fill Finish Market Dynamics:

Market Enablers:

  • Escalating the need for vaccines and other biologics product Across Market
  • Recent Covid-19 pandemic has intensified the need for effective vial filling machines and fill/finish procedures
  • Growing Biopharmaceutical Market: Market was estimated around $341.8 billion in 2021 and growing at a CAGR of ~8%
  • Integration of Advance Technological Tools in Existing Systems
  • Rising Production Capacity

Contract development and manufacturing organizations have been under intense pressure from the beginning of the pandemic to deliver fill & finish services to meet this surging demand. In optimizing the process efficiency, catering wide-range of production scale to both type of companies (mid-size and big companies).

Challenges: 

Report has covered the in-depth analysis around, current and future challenges expected to be faced by the market. Few of the challenges listed below:

  • Regulatory Scrutiny
  • Handling Sensitive Biologics
  • Risk Associated with Work Flow
  • Cost Associated with Meeting Regulatory Guidelines and Integration of Automation
  • Challenges Companies Face After Completing an Aseptic Fill Finish: 
    • Intricacy with the levels of viscosity
    • Adherence with GMP regulations 

Segmentation Outlook: End User Analysis: 

Biopharmaceutical companies are the top customers for Fill-Finish CDMOs, taking ~56% of the total market share during base year. This share is expected to gain further during analysis period. A Surging number of small to medium-sized, biopharma and biotech companies are using CDMOs services for “end to-end” manufacturing of their offerings. The major benefits of such a business model offers are lower development costs and risk minimization. CDMOs have all necessary equipment in place and most of all, great technical skills that can help smaller enterprises to reduce the time-to-market and lower the chances for project failure.

Regional Synopsis:

North America has the legacy of been the most dominant region in the global fill finish manufacturing market.  This region accounts for ~48.6% of the total market share. Having the presence of large number of players, favourable government policies, rising investment among others are the various factors contributing to the overall market growth. Moreover, the high demand for injectable drugs and biologics is been fuelling the growth of the fill finish manufacturing market in the region. 

Europe is placed at the 2nd place and contributing nearly 26.5% of market share in terms of revenue. These statistics may not likely to change significantly in the near future. Though APAC region is also not devoid of such opportunities, where lucrative opportunities are lies ahead during the analysis period in countries such as China, India and others.

Strategic Market Developments: 

Report has covered the in-depth analysis on impact of current and expected developments on overall market statistics. Competitors insider understanding would help in gaining real market insights. 

Market Segmentation:

Our in-depth analysis of the global Fill Finish Manufacturing market includes the following segments:

Global Fill Finish Manufacturing Market
Base Year:2021Forecast Period:2024-2031
Historical Data:                     2021Market Size in 2021:USD 8,301.7 Million
Forecast Period 2024-35 CAGR:9.68%Market Size in 2031:USD 20,915.5 Million
Segments Covered:By Product

 

  • Prefilled Syringes
    • Design
      • Single-Chamber Prefilled Syringes
      • Dual-Chamber Prefilled Syringes
      • Customized-Chamber Prefilled Syringes
    • Usability Type
      • Disposable
      • Reusable
    • Packaging Type
      • Glass-Prefilled Syringes
      • Plastic-Prefilled Syringes
    • Application
      • Diabetes
      • Anaphylaxis
      • Rheumatoid Arthritis
      • Vaccine
      • Bio pharmacy
      • Antithrombotic
      • Others
  • Combination Products
    • Single Entity Combination Products
    • Co-packaged Combination Products
    • Cross-labeled Combination Products
By End User
  • Contract Manufacturing Organizations
  • Biopharmaceutical Companies
  • Pharmaceutical Companies
By Region
  • North America (U.S., Canada)
  • Europe (United Kingdom, Germany, France, Italy, Spain, Rest of Europe)
  • Asia-Pacific (China, India, Japan, South Korea, Rest of APAC)
  • Middle East & Africa (Saudi Arabia, Israel, UAE, South Africa, Rest of MEA)
  • South America (Brazil, Mexico, Argentina, Rest of South America)
Key Market Drivers:
  • Escalating the need for vaccines and other biologics product Across Market
  • Recent Covid-19 pandemic has intensified the need for effective vial filling machines and fill/finish procedures
Key Market Restraints:
  • Regulatory scrutiny
  • Aseptic filling
Key Trends:
  • Cost Associated with Technological Integration
Companies Covered in the Report:
  • Becton, Dickinson and Company
  • Gerresheimer
  • SCHOTT AG
  • West Pharmaceutical Services, Inc.
  • Baxter International Inc.
  • B. Braun Melsungen AG
  • Catalent, Inc.
  • AbbVie
  • MedXL, Inc.
  • NIPRO Corporation
  • Terumo Corporation
  • Taisei Kako Co., Ltd.
  • Otsuka Pharmaceutical 
  • Other Major Players